NCT00774111View on ClinicalTrials.gov

GSK1349572 Drug Interaction Study With Etravirine

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Healthy Subjects

Interventions

DRUG

GSK1349572

GSK1349572 50 mg in combination with Etravirine

Trial Locations (1)

14202

GSK Investigational Site, Buffalo

Sponsors

Lead Sponsor

GlaxoSmithKline

Collaborators (1)

All Listed Sponsors

collaborator

Shionogi

INDUSTRY

lead

GlaxoSmithKline

INDUSTRY